Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Davide Lazzarotto

12PUBLICATIONS

35CO-AUTHORS

Psychology of ageingHaematological tumoursMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Aug 26, 2025

Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.

Davide Lazzarotto, Anna Maria Testi, Matteo Fanin

|Aug 11, 2025

Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.

Patrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti

|Feb 13, 2025

New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.

Giulia Battaglia, Davide Lazzarotto, Ilaria Tanasi

|Sep 14, 2024

Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax.

Stefano Cordella, Davide Giusti, Eleonora De Bellis

|Jun 19, 2024

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission.

Anna Candoni, Patrizia Chiusolo, Davide Lazzarotto

|Sep 28, 2023

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.

Nicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis

Pageof 2

Frequent Collaborators

5 joint publications

Anna Candoni

3 joint publications

Maria Ilaria Del Principe

3 joint publications

Marco Cerrano

2 joint publications

Nicola Stefano Fracchiolla

2 joint publications

Mario Delia

2 joint publications

Chiara Sartor

2 joint publications

Patrizia Zappasodi

2 joint publications

Nicola Stefano Fracchiolla

2 joint publications

Elisa Buzzatti

2 joint publications

Mariarita Sciumè

Frequent Collaborators

5 joint publications

Anna Candoni

3 joint publications

Maria Ilaria Del Principe

3 joint publications

Marco Cerrano

2 joint publications

Nicola Stefano Fracchiolla

Top Related Videos

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on : Mar 22, 2012

See more related videos

Top Related Videos

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on : Mar 22, 2012

See more related videos